| 2023 |
In silico lead optimization and synthesis of a new series of thieno[3,2-c]quinoline with antiproliferative activity on RET-dependent medullary thyroid cancer cells |
Abstract in atti di convegno pubblicato in volume |
Vai |
| 2023 |
Synthesis of new antiproliferative 1,3,4-substituted-pyrrolo[3,2-c]quinoline derivatives, biological and in silico insights |
Articolo in rivista |
Vai |
| 2023 |
In Silico Design of New Dual Inhibitors of SARS-CoV-2 MPRO through Ligand- and Structure-Based Methods |
Articolo in rivista |
Vai |
| 2023 |
In Silico Mixed Ligand/Structure-Based Design of New CDK-1/PARP-1 Dual Inhibitors as Anti-Breast Cancer Agents |
Articolo in rivista |
Vai |
| 2023 |
Design and Synthesis of Novel Thieno[3,2-c]quinoline Compounds with Antiproliferative Activity on RET-Dependent Medullary Thyroid Cancer Cells |
Articolo in rivista |
Vai |
| 2022 |
Antiproliferative Activity Predictor: un nuovo tool in silico per predire l’attività antiproliferativa nei confronti del pannello NCI60 |
Abstract in atti di convegno pubblicato in volume |
Vai |
| 2022 |
One pot-like regiospecific access to 1-aryl-1H-pyrazol-3(2H)-one derivatives and evaluation of the anticancer activity |
Articolo in rivista |
Vai |
| 2022 |
Antiproliferative Activity Predictor: A New Reliable In Silico Tool for Drug Response Prediction against NCI60 Panel |
Articolo in rivista |
Vai |
| 2022 |
Targeting SARS-CoV-2 Main Protease for Treatment of COVID-19: Covalent Inhibitors Structure-Activity Relationship Insights and Evolution Perspectives |
Articolo in rivista |
Vai |
| 2021 |
Quinoline anticancer agents active on DNA and DNA-interacting proteins: From classical to emerging therapeutic targets |
Articolo in rivista |
Vai |
| 2021 |
Antiproliferative properties and g-quadruplex-binding of symmetrical naphtho[1,2-b:8,7-b’]dithiophene derivatives |
Articolo in rivista |
Vai |
| 2021 |
Identification of biological targets through the correlation between cell line chemosensitivity and protein expression pattern |
Review essay (rassegna critica) |
Vai |
| 2021 |
Off-target-based design of selective hiv-1 protease inhibitors |
Articolo in rivista |
Vai |
| 2021 |
In silico identification of small molecules as new cdc25 inhibitors through the correlation between chemosensitivity and protein expression pattern |
Articolo in rivista |
Vai |
| 2020 |
Quinoline-based molecules targeting c-Met, EGF, and VEGF receptors and the proteins involved in related carcinogenic pathways |
Articolo in rivista |
Vai |
